NEW YORK ( TheStreet) -- Shares of Insmed (Nasdaq: INSM) were gapping down Tuesday morning with an open price 41% lower than Monday's closing price. The stock closed at $11.35 Monday and opened today's trading at $6.70. The average volume for Insmed has been 217,300 shares per day over the past 30 days. Insmed has a market cap of $285.3 million and is part of the health care sector and drugs industry. Shares are up 79.9% year to date as of the close of trading on Monday. Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. TheStreet Ratings rates Insmed as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. You can view the full Insmed Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.